aap Implantate AG Logo

aap Implantate AG

ISIN: DE000A3H2101 | Ticker: AAQ1 | LEI: 39120001TRQTQ01LPP41

About aap Implantate AG

Company Description

We are a globally active medical technology company based in Berlin, Germany. We develop, manufacture and market products for trauma. Our IP-protected portfolio includes besides the innovative anatomical plating system LOQTEQ a wide range of cannulated screws. In addition, we have an innovation pipeline with promising development projects such as our antibacterial silver coating technology and our magnesium-based implants. These technologies address critical and unmet needs in trauma.
While we sell our products in Germany directly to hospitals, purchasing groups, and hospital groups, at international level we primarily use a broad network of distributors in around 25 countries. In the US we pursue a hybrid distribution strategy with our subsidiary aap Implants Inc. Distribution is carried out both through distribution agents and partnerships with global orthopedic companies.

Year founded

1990

Served area

Europe

Headcount

148

Headquarters

Lorenzweg 5, 12099 Berlin – Germany

Filings & Publications

2021

Report Q1 H1 Q3 FY
Consolidated Report GER GER
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

2020

Report Q1 H1 Q3 FY
Consolidated Report GER
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

2022

Report Q1 H1 Q3 FY
Consolidated Report GER
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
30.03.23 Hahn, Marek Board Other 52,920.00 €
30.03.23 Mierzejewska, Agnieszka Board Other 26,800.20 €
30.03.23 Merval AG Close relation Other 140,000.00 €
30.03.23 Deepblue Holding AG Close relation Other 249,999.40 €
30.03.23 di Girolamo, Rubino Board Other 83,743.80 €
03.02.22 Merval AG Close relation Other 650,000.47 €
28.10.21 Active Ownership Fund SICAV-FIS SCS Close relation Other 60,792,157.00 €
27.10.21 Merval AG Close relation Other 318,324.60 €
27.10.21 Visser, Biense Supervisory board Other 3,573.90 €

Shareholder information

Shares outstanding

5,959,531

IPO

May 10, 1999

Designated Sponsor(s)

BankM AG

Stock exchange(s)

Frankfurt Stock Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.